Background: Although many studies have assessed the diagnostic utility of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the context of a specific disease, few studies have assessed the overall diagnostic yield, sensitivity, and negative predictive value in patients with isolated mediastinal and hilar lymphadenopathy (IMHL). Objective: We evaluated the performance of EBUS-TBNA for diagnosing IMHL in a population with a high prevalence of concurrent or preexisting non-pulmonary malignancy. Methods: A retrospective chart review of patients who underwent EBUS-TBNA from October 2008 to April 2014 was performed to identify patients with IMHL. Patients with known or suspected primary pulmonary malignancy were excluded. When available, EBUS-TBNA results were cross-referenced with further diagnostic investigation or clinical diagnosis based on follow-up. Results: EBUS-TBNA was used to sample 765 lymph nodes from 350 patients. One hundred and fourteen (33.3%) patients had a concurrent or preexisting non-pulmonary malignancy. The overall yield of EBUS-TBNA for specific diagnosis was 300/350 (86%). The diagnostic yield for sarcoidosis, lymphoproliferative disease, metastatic lymphadenopathy from extrathoracic malignancy, and necrotizing granuloma was 123/149 (83%), 27/33 (82%), 20/25 (80%), and 13/19 (68%), respectively. Amongst 50 patients with non-diagnostic EBUS-TBNA, 25 yielded an insufficient sample and another 25 yielded only benign lymphoid material which was not representative of the underlying pathology. Overall, EBUS-TBNA had a sensitivity of 89%, a diagnostic yield of 86%, and a negative predictive value of 79%. Conclusion: For patients with isolated hilar or mediastinal lymphadenopathy and a high background prevalence of concurrent and preexisting non-pulmonary malignancy, EBUS-TBNA is a reliable first-line diagnostic investigation.

1.
Kirchner J, Kirchner EM, Goltz JP, Lorenz V-W, Kickuth R: Prevalence of enlarged mediastinal lymph nodes in heavy smokers - a comparative study. Eur Radiol 2011;21:1594-1599.
2.
Souza CA, Müller NL, Lee KS, Johkoh T, Mitsuhiro H, Chong S: Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. AJR Am J Roentgenol 2006;186:995-999.
3.
Joffre F, Remy J, Remy-Jardin M, Chabbert VR, Canevet G, Baixas CC, et al: Mediastinal lymphadenopathy in congestive heart failure: a sequential CT evaluation with clinical and echocardiographic correlations. Eur Radiol 2004;14:881-889.
4.
Lewin S, Goldberg L, Dec GW: The spectrum of pulmonary abnormalities on computed chest tomographic imaging in patients with advanced heart failure. Am J Cardiol 2000;86:98-100.
5.
Yasufuku K, Pierre A, Darling G, de Perrot M, Waddell T, Johnston M, et al: A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011;142:1393-2400.e1.
6.
Agarwal R, Srinivasan A, Aggarwal AN, Gupta D: Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med 2012;106:883-892.
7.
Navani N, Nankivell M, Woolhouse I, Harrison RN, Munavvar M, Oltmanns U, et al: Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter study. J Thorac Oncol 2011;6:1505-1509.
8.
Rao AK, Ben-Or S, Bowling MR: Bronchoscopic myths and legends transbronchial needle aspiration of mediastinal and hilar lymph nodes in the diagnosis of lymphoma. Clin Pulm Med 2014;21:50-52.
9.
Navani N, Lawrence DR, Kolvekar S, Hayward M, McAsey D, Kocjan G, et al: Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med 2012;186:255-260.
10.
Madan K, Mohan A, Ayub II, Jain D, Hadda V, Khilnani GC, et al: Initial experience with endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) from a tuberculosis endemic population. J Bronchology Interv Pulmonol 2014;21:208-214.
11.
Evison M, Crosbie PAJ, Morris J, Martin J, Barber PV, Booton R: A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA. BMJ Open Respir Res 2014;1:e000040.
12.
Boujaoude Z, Dahdel M, Pratter M, Kass J: Endobronchial ultrasound with transbronchial needle aspiration in the diagnosis of bilateral hilar and mediastinal lymphadenopathy. J Bronchology Interv Pulmonol 2012;19:19-23.
13.
Yasufuku K, Nakajima T, Fujiwara T, Yoshino I, Keshavjee S: Utility of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal masses of unknown etiology. Ann Thorac Surg 2011;91:831-836.
14.
Goyal A, Gupta D, Agarwal R, Bal A, Nijhawan R, Aggarwal AN: Value of different bronchoscopic sampling techniques in diagnosis of sarcoidosis: a prospective study of 151 patients. J Bronchology Interv Pulmonol 2014;21:220-226.
15.
Kennedy MP, Jimenez CA, Mhatre AD, Morice RC, Eapen GA: Clinical implications of granulomatous inflammation detected by endobronchial ultrasound transbronchial needle aspiration in patients with suspected cancer recurrence in the mediastinum. J Cardiothorac Surg 2008;3:8.
16.
Brincker H: Sarcoid reactions in malignant tumours. Cancer Treat Rev 1986;13:147-156.
17.
Umezu H, Chida M, Inoue T, Araki O, Tamura M, Tatewaki M, et al: Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease. Gen Thorac Cardiovasc Surg 2010;58:434-437.
18.
Iqbal S, DePew ZS, Kurtin PJ, Sykes AMG, Johnson GB, Edell ES, et al: Endobronchial ultrasound and lymphoproliferative disorders: a retrospective study. Ann Thorac Surg 2012;94:1830-1834.
19.
Talebian-Yazdi M, Bartheld von B, Waaijenborg F, Nabes H, Venmans B, Veselic-Charvat M, et al: Endosonography for the diagnosis of malignant lymphoma presenting with mediastinal lymphadenopathy. J Bronchology Interv Pulmonol 2014;21:298-305.
20.
Moonim MT, Breen R, Fields PA, Santis G: Diagnosis and subtyping of de novo and relapsed mediastinal lymphomas by endobronchial ultrasound needle aspiration. Am J Respir Crit Care Med 2013;188:1216-1223.
21.
Grosu HB, Iliesiu M, Caraway NP, Medeiros LJ, Lei X, Jimenez CA, et al: Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis and subtyping of lymphoma. Ann Am Thorac Soc 2015;12:1336-1344.
22.
Ko HM, da Cunha Santos G, Darling G, Pierre A, Yasufuku K, Boerner SL, et al: Diagnosis and subclassification of lymphomas and non-neoplastic lesions involving mediastinal lymph nodes using endobronchial ultrasound-guided transbronchial needle aspiration. Diagn Cytopathol 2013;41:1023-1030.
23.
Tilly H, Vitolo U, Walewski J, da Silva MG, Shpilberg O, Andre M, et al: Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(suppl 7):vii78-vii82.
24.
Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Byrd JC, Czuczman MS, et al: NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas. J Natl Compr Canc Netw 2010;8:288-334.
25.
Song J-U, Park HY, Jeon K, Koh W-J, Suh GY, Chung MP, et al: The role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal and hilar lymph node metastases in patients with extrapulmonary malignancy. Intern Med 2011;50:2525-2532.
26.
Tournoy KG, Govaerts E, Malfait T, Dooms C: Endobronchial ultrasound-guided transbronchial needle biopsy for M1 staging of extrathoracic malignancies. Ann Oncol 2010;22:127-131.
27.
Wahidi MM, Herth F, Yasufuku K, Shepherd RW, Yarmus L, Chawla M, et al: Technical aspects of endobronchial ultrasound-guided transbronchial needle aspiration. Chest 2016;149:816-835.
28.
van der Heijden EHFM, Casal RF, Trisolini R, Steinfort DP, Hwangbo B, Nakajima T, et al: Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer. Respiration 2014;88:500-517.
29.
Oki M, Saka H, Kitagawa C, Kogure Y, Murata N, Adachi T, et al: Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: a randomized study. Respiration 2013;85:486-492.
30.
Nakajima T, Yasufuku K, Saegusa F, Fujiwara T, Sakairi Y, Hiroshima K, et al: Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for nodal staging in patients with lung cancer. Ann Thorac Surg 2013;95:1695-1699.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.